Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase
- 3 August 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 239 (1-3) , 39-45
- https://doi.org/10.1016/0014-2999(93)90973-l
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The TiPS lecture: Functional aspects of the neuronal uptake of noradrenalinePublished by Elsevier ,2003
- Effect of nitecapone and clorgyline, given intracerebro-ventricularly on L-dopa metabolism in the rat brainNeuroReport, 1992
- Extracellular Concentrations of Dopamine and Metabolites in the Rat Caudate After Oral Administration of a Novel Catechol‐O‐Methyltransferase Inhibitor Ro 40–7592Journal of Neurochemistry, 1992
- Effect of a Novel Catechol-O-Methyltransferase Inhibitor, Nitecapone, on the Metabolism of l-Dopa in Healthy VolunteersClinical Neuropharmacology, 1990
- Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's DiseaseBasic & Clinical Pharmacology & Toxicology, 1990
- Catechol-O-methyltransferase activity in human and rat small intestineLife Sciences, 1988
- Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferaseLife Sciences, 1988
- Intracerebral dialysis: Direct evidence for the utility of 3-MT measurements as an index of dopamine releaseLife Sciences, 1987
- PimozideDrugs, 1976
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966